Dreavent Capital is a strategic investment firm focused on funding biotech therapeutics companies. They invest in early-stage biotechnology and healthcare companies, with a focus on therapeutics in areas such as Oncology, Neurology, Cardiovascular & Metabolic, and Immunology. Their investment strategy spans Europe and North America, and they are strategically located in a prominent biotech hub.
Focus Areas
Investment Types
Notable Investments
